ConductScience.org, home

Paper41367883

Fatal Steroid-Refractory Autoimmune Encephalitis Following Sequential Immune Checkpoint Inhibitor Therapy in Squamous Non-Small Cell Lung Cancer.

Huang J and 3 others. Onco Targets Ther, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Fatal Steroid-Refractory Autoimmune Encephalitis Following Sequential Immune Checkpoint Inhibitor Therapy in Squamous Non-Small Cell Lung Cancer. Papers, record 41367883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41367883

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fatal Steroid-Refractory Autoimmune Encephalitis Following Sequential Immune Checkpoint Inhibitor Therapy in Squamous Non-Small Cell Lung Cancer.
PubMed
Journal
Onco Targets Ther
PubMed
Year
2025
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-12-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang JJianfang
2Wang JJian
3Zheng DDingting
4Chen JJianxin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136709038Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC.Ann Oncol2023https://conductscience.org/library/papers/36709038PubMed
240208442MLG2Net: Molecular Global Graph Network for Drug Response Prediction in Lung Cancer Cell Lines.J Med Syst2025https://conductscience.org/library/papers/40208442PubMed
327271951Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.JAMA Neurol2016https://conductscience.org/library/papers/27271951PubMed
431454760Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.Neurol Neuroimmunol Neuroinflamm2019https://conductscience.org/library/papers/31454760PubMed
533812689Neurological complications of immune checkpoint inhibitor cancer immunotherapy.J Neurol Sci2021https://conductscience.org/library/papers/33812689PubMed
631552550Epidemiology of paraneoplastic neurological syndromes: a population-based study.J Neurol2020https://conductscience.org/library/papers/31552550PubMed
728626408PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis.Case Rep Oncol2017https://conductscience.org/library/papers/28626408PubMed
834120259Immune checkpoint inhibitors-related encephalitis in melanoma and non-melanoma cancer patients: a single center experience.Support Care Cancer2021https://conductscience.org/library/papers/34120259PubMed
937523012Hyper-methylation of ABCG1 as an epigenetics biomarker in non-small cell lung cancer.Funct Integr Genomics2023https://conductscience.org/library/papers/37523012PubMed
1029517954Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary.J Oncol Pract2018https://conductscience.org/library/papers/29517954PubMed
1129441072Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature.Front Immunol2018https://conductscience.org/library/papers/29441072PubMed
1235741658Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature.Brain Sci2022https://conductscience.org/library/papers/35741658PubMed
1333454891Neurotoxicities associated with immune checkpoint inhibitor therapy.J Neurooncol2021https://conductscience.org/library/papers/33454891PubMed
1436950965Immune checkpoint inhibitor-induced autoimmune encephalitis in metastatic squamous cell lung cancer.Immunotherapy2023https://conductscience.org/library/papers/36950965PubMed
1527718847Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.N Engl J Med2016https://conductscience.org/library/papers/27718847PubMed
1633653902Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review.Neurology2021https://conductscience.org/library/papers/33653902PubMed
1732086972Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.Ann Neurol2020https://conductscience.org/library/papers/32086972PubMed
1833268558Bilateral Thalamic Lesions Associated With Atezolizumab-Induced Autoimmune Encephalitis.Neurology2021https://conductscience.org/library/papers/33268558PubMed
1930073101Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma.Case Rep Neurol Med2018https://conductscience.org/library/papers/30073101PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41367883

GET https://conductscience.org/api/papers/v1/41367883/authors